1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Currax Pharmaceuticals Acquires Pernix Therapeutics Holdings

M&A Deal Summary

Currax Pharmaceuticals Acquires Pernix Therapeutics Holdings

On May 1, 2019, Currax Pharmaceuticals acquired life science company Pernix Therapeutics Holdings for 76M USD

Acquisition Highlights
  • This is Currax Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Currax Pharmaceuticals’ largest (disclosed) transaction.
  • This is Currax Pharmaceuticals’ 1st transaction in the United States.
  • This is Currax Pharmaceuticals’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2019-05-01
Target Pernix Therapeutics Holdings
Sector Life Science
Buyer(s) Currax Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 76M USD
Advisor(s) Guggenheim Securities
Ernst & Young Capital Advisors (Financial)
Davis Polk & Wardwell (Legal)

Target

Pernix Therapeutics Holdings

Morristown, New Jersey, United States
Pernix Therapeutics Holdings, Inc. is a pharmaceutical company developing branded and generic pediatric products. Pernix Therapeutics was founded in 1996 and is based in Morristown, New Jersey.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Currax Pharmaceuticals

Morristown, New Jersey, United States
Category Company
Sector Life Science
DESCRIPTION

Currax Pharmaceuticals LLC is a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs within the U.S. market. Currax distributes a range of both Branded and generic pharmaceutical products, including Silenor®, Treximet®, Zohydro® ER with BeadTek® and the authorized generic of Treximet®.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 2
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 2
Year: 2019 M&A 1 of 2
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-27 Nalpropion Pharmaceuticals

San Diego, California, United States

Nalpropion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of weight loss. Nalpropion Pharmaceuticals was formed in 2018 and is based in San Diego, California.

Buy -
Mergr

Solution for

Product

Company

Legal